Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00907075 · ClinicalTrials.gov registry record · NA

Pilot Study to Assess Adherence to a Novel Eating System in Men and Women With Type 2 Diabetes Mellitus

A NA study, sponsored by Mondelēz International.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT00907075: Completed NA study, sponsored by Mondelēz International.

NCT00907075 is a NA study that has completed, run by Mondelēz International. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00907075, a NA study, has completed, sponsored by Mondelēz International.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

The purpose of this pilot study is to assess adherence to a Novel Eating System (NES) with and without energy restriction.

Interventions

  • BEHAVIORAL NES With Energy Restriction
  • BEHAVIORAL NES Without Energy Restriction

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2009-03
Est. Completion 2009-09
Phase NA
Mondelēz International

7 total trials

What the finished NCT00907075 record still lists

NCT00907075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which NES With Energy Restriction is the first listed.

NCT00907075 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00907075 about?

NCT00907075 is a clinical study titled "Pilot Study to Assess Adherence to a Novel Eating System in Men and Women With Type 2 Diabetes Mellitus". The purpose of this pilot study is to assess adherence to a Novel Eating System (NES) with and without energy restriction.

What is the current status of trial NCT00907075?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2009-03. Estimated completion is 2009-09.

What interventions are being tested in trial NCT00907075?

The interventions under investigation include: NES With Energy Restriction (BEHAVIORAL), NES Without Energy Restriction (BEHAVIORAL).

Who is sponsoring clinical trial NCT00907075?

This trial is sponsored by Mondelēz International, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00907075's enrollment target sits among peer trials

51 1279th of 2000 higher than 722 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00907075, the US trial registry maintained by the National Library of Medicine. NCT00907075 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.